Phase I study of selinexor, ixazomib and low-dose dexamethasone in patients with relapsed or refractory multiple myeloma
2019
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
3
References
5
Citations
NaN
KQI